| 000 | 00942 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250516012241.0 | ||
| 264 | 0 | _c20110506 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1473-5571 | ||
| 024 | 7 |
_a10.1097/QAD.0b013e328340871d _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilson, David P | |
| 245 | 0 | 0 |
_aEvidence is still required for treatment as prevention for riskier routes of HIV transmission. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cNov 2010 |
||
| 300 |
_a2891-2; author reply 2892-3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tAIDS (London, England) _gvol. 24 _gno. 18 _gp. 2891-2; author reply 2892-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e328340871d _zAvailable from publisher's website |
| 999 |
_c20361465 _d20361465 |
||